Vanda Pharmaceuticals
VNDA
#8239
Rank
NZ$0.53 B
Marketcap
NZ$8.95
Share price
-3.36%
Change (1 day)
13.61%
Change (1 year)

Vanda Pharmaceuticals (VNDA) - Net assets

Net assets on the balance sheet as of March 2026 : NZ$0.48 Billion

According to Vanda Pharmaceuticals's latest financial reports the company has NZ$0.48 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Vanda Pharmaceuticals - Net assets on balance sheet (from 2005 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$NZ$0.56 B-40.84%
2024-12-31$NZ$0.95 B10.82%
2023-12-31$NZ$0.86 B3.77%
2022-12-31$NZ$0.83 B12.33%
2021-12-31$NZ$0.73 B17.68%
2020-12-31$NZ$0.62 B2.95%
2019-12-31$NZ$0.61 B48.61%
2018-12-31$NZ$0.41 B121.95%
2017-12-31$NZ$0.18 B-2.42%
2016-12-31$NZ$0.18 B-2.45%
2015-12-31$NZ$0.19 B-5.3%
2014-12-31$NZ$0.20 B282.26%
2013-12-31$NZ$53.69 M345.95%
2012-12-31$NZ$12.04 M-71.93%
2011-12-31$NZ$42.89 M-12.3%
2010-12-31$NZ$48.9 M54.24%
2009-12-31$NZ$31.7 M-60.01%
2008-12-31$NZ$79.3 M-27.45%
2007-12-31$NZ$0.10 B187.8%
2006-12-31$NZ$37.97 M-15.35%
2005-12-31$NZ$44.86 M100.79%
2004-12-31$NZ$22.34 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
NZ$140.24 B 28,816.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$67.24 B 13,764.62%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$156.16 B 32,099.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$53.89 B 11,011.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$79.34 B 16,259.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$34.72 B 7,059.72%๐Ÿ‡บ๐Ÿ‡ธ USA